Induction Chemotherapy | Index of all Induction Chemotherapy Related Articles

Main Portal | Chemotherapy Articles | Chemotherapy Links | Chemotherapy Partners | Chemotherapy Sitemap

Index of All Articles in the Induction Chemotherapy Category

Defined Tag: Induction Chemotherapy

Understanding The Basics Of Induction Chemotherapy

While many people understand that chemotherapy is the administration of a mixture of drugs designed to reduce and in some cases destroy malignancies within the body, not everyone realizes there are different types of chemotherapy treatment One such approac
Read More...

Other green Health Medical Topics To Check Out:

acupuncture acupressure drug addiction prescription

free DNA test general hospital happening

hysterectomy recovery laboratory equipment supply

nursing job part of a microscope

surgery information wheelchair

Early Menopause Symptom alcohol abuse symptom

lyme disease symptom teeth whitening

chemotherapy side effects senior health care

alzheimers symptom sterile processing environment

geriatric doctor

Chemotherapy News and Events

Medical Power Search Our specialised search engine is designed to look for the right information for your health search enquiry. Type in your search key now and Medical Power Search will return you laser-targetted search results to match your needs.

Carboplatin Chemotherapy News

U.S. Phase 2 Combination Clinical Trial For Non-Small Cell Lung Cancer Patients With K-RAS Or EGFR-Activated Tumours (Medical News Today)

Wed, 03 Sep 2008 11:10:02 GMT

Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours.

Oncolytics initiates US Phase II lung cancer trial (Pharmaceutical Business Review)

Wed, 03 Sep 2008 00:39:51 GMT

Oncolytics Biotech has announced that following the FDA review, the company is initiating a US Phase II clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer with K-RAS or EGFR-activated tumors.

Cytopia Commences Second Phase II Study In Brain Cancer (Medical News Today)

Fri, 05 Sep 2008 10:14:43 GMT

Cytopia Limited (ASX:CYT) announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM).